首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Minerva cardioangiologica

缩写:MINERVA CARDIOANGIOL

ISSN:0026-4725

e-ISSN:1827-1618

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引571条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Roger D Dias,Julie A Shah,Marco A Zenati Roger D Dias
The tremendous and rapid technological advances that humans have achieved in the last decade have definitely impacted how surgical tasks are performed in the operating room (OR). As a high-tech work environment, the contemporary OR has inco...
Fausto Roccasalva,Giuseppe Ferrante Fausto Roccasalva
Current guidelines recommend a duration of dual antiplatelet therapy (DAPT) with aspirin and oral P2Y12 receptor inhibitors following percutaneous coronary intervention (PCI) with second-generation drug-eluting stents (DES) of 6 months for ...
Marco A Perrone,Massimiliano Macrini,Alessio Maregnani et al. Marco A Perrone et al.
Background: High sensitivity cardiac troponins I (hs-cTnI) and T (hs-cTnT) and natriuretic peptides (BNP and NT-proBNP) are universally recognized as cardiac reference biomarkers in patients with acute coronary syndromes ...
Claudio H da Silva,Rhanany A Palozi,Priscila de Souza et al. Claudio H da Silva et al.
Background: Nothofagin is a mono-C-glycoside of 4,2',4',6'-tetrahydroxy-dihydrochalcone that is commonly found in Aspalathus linearis, Nothofagus fusca, and Leandra dasytricha. A wide range of biological effects has been ...
Milan Milojevic,Petar Milacic,Ivana Petrovic et al. Milan Milojevic et al.
This article reviews the context and evidence of recent myocardial revascularization trials on PCI versus CABG with particular emphasis on patient selection and treatment of surgical patients. Moreover, one of our intended purposes is to id...
Andrea Buono,Alfonso Ielasi,Antonio Colombo Andrea Buono
Bioresorbable scaffolds (BRS) have been introduced in the last decade in percutaneous coronary interventions. Despite several advantages being postulated, the negative results from the mid-term follow-up of the Absorb trials have tempered e...
Gianni Belcaro,Maria R Cesarone,Valeria Scipione et al. Gianni Belcaro et al.
Background: The aim of this supplement registry study was the evaluation of possible benefits of Robuvit® (oak wood extract) as a standardized supplement (in an 8-week registry) in stable, mild, heart failure patients. ...